Sun Pharmaceutical Industries share price gains 0.64% to ₹1,751.20 on October 27

Key Takeaways

• Sun Pharma ended at ₹1,751.20, gaining ₹11.20 or 0.64%, after opening at the displayed session low of ₹1,740.
• The closing price remained below the 50-day, 100-day and 200-day DMAs by ₹74.30, ₹88.50 and ₹65.80.
• Six-month and one-year returns were positive at 8.07% and 3.07%, while one- and three-month performance remained negative.

Sun Pharmaceutical Industries share price closed October 27 at ₹1,751.20, rising ₹11.20 or 0.64%. The stock opened at ₹1,740, matching both the rounded previous close and the displayed session low. It subsequently reached a high of ₹1,768. The resulting day range was ₹28. Sun Pharma finished ₹11.20 above the low and ₹16.80 below the high, while the opening-to-closing gain also measured ₹11.20.

Volume reached 1,571,184 shares. The closing price remained below all three longer moving averages. The 50-day DMA stood at ₹1,825.50, leaving the stock ₹74.30 lower. The 100-day DMA was ₹1,839.70, a difference of ₹88.50. Sun Pharma's 200-day DMA stood at ₹1,817, putting the October 27 close ₹65.80 below that level.

The stock's 52-week range extended from ₹1,584 to ₹2,047. At ₹1,751.20, Sun Pharma was ₹167.20 above its annual low and ₹295.80 below the high. This positioned the final price closer to the lower boundary of its ₹463 annual span.

Return periods shifted from negative in the shorter windows to positive in the longer ones. The one-month return was -5.45% and the three-month figure was -9.78%. Six-month performance stood at 8.07%, while the one-year return was 3.07%. The gap between the three-month and six-month readings reached 17.85 percentage points.

October 27 brought a moderate daily gain after the stock began the session at its displayed low. The close remained below each of the longer moving-average levels, while the return figures showed a clear difference between weaker one- and three-month performance and positive six-month and one-year readings.